209 related articles for article (PubMed ID: 29024742)
1. CYP-mediated drug metabolism in the brain impacts drug response.
McMillan DM; Tyndale RF
Pharmacol Ther; 2018 Apr; 184():189-200. PubMed ID: 29024742
[TBL] [Abstract][Full Text] [Related]
2. The unique regulation of brain cytochrome P450 2 (CYP2) family enzymes by drugs and genetics.
Miksys S; Tyndale RF
Drug Metab Rev; 2004 May; 36(2):313-33. PubMed ID: 15237857
[TBL] [Abstract][Full Text] [Related]
3. Cytochrome P450 enzymes in the brain: emerging evidence of biological significance.
Ferguson CS; Tyndale RF
Trends Pharmacol Sci; 2011 Dec; 32(12):708-14. PubMed ID: 21975165
[TBL] [Abstract][Full Text] [Related]
4. Cytochrome P450 enzymes and metabolism of drugs and neurotoxins within the mammalian brain.
Stocco MR; Tyndale RF
Adv Pharmacol; 2022; 95():73-106. PubMed ID: 35953164
[TBL] [Abstract][Full Text] [Related]
5. Cytochrome P450 in the brain; a review.
Hedlund E; Gustafsson JA; Warner M
Curr Drug Metab; 2001 Sep; 2(3):245-63. PubMed ID: 11513329
[TBL] [Abstract][Full Text] [Related]
6. Potential role of cerebral cytochrome P450 in clinical pharmacokinetics: modulation by endogenous compounds.
Gervasini G; Carrillo JA; Benitez J
Clin Pharmacokinet; 2004; 43(11):693-706. PubMed ID: 15301574
[TBL] [Abstract][Full Text] [Related]
7. Xenobiotic metabolizing enzymes in the central nervous system: Contribution of cytochrome P450 enzymes in normal and pathological human brain.
Dutheil F; Beaune P; Loriot MA
Biochimie; 2008 Mar; 90(3):426-36. PubMed ID: 17997991
[TBL] [Abstract][Full Text] [Related]
8. Cytochrome P450 in the central nervous system as a therapeutic target in neurodegenerative diseases.
Navarro-Mabarak C; Camacho-Carranza R; Espinosa-Aguirre JJ
Drug Metab Rev; 2018 May; 50(2):95-108. PubMed ID: 29451034
[TBL] [Abstract][Full Text] [Related]
9. Cytochrome P450-mediated drug metabolism in the brain.
Miksys S; Tyndale RF
J Psychiatry Neurosci; 2013 May; 38(3):152-63. PubMed ID: 23199531
[TBL] [Abstract][Full Text] [Related]
10. Oxidation of 3-aminobenzanthrone, a human metabolite of carcinogenic environmental pollutant 3-nitrobenzanthrone, by cytochromes P450 - similarity between human and rat enzymes.
Mizerovska J; Dracinska H; Arlt VM; Schmeiser HH; Frei E; Stiborova M
Neuro Endocrinol Lett; 2009; 30 Suppl 1():52-9. PubMed ID: 20027145
[TBL] [Abstract][Full Text] [Related]
11. Assessment of cytochrome P450 fluorometric substrates with rainbow trout and killifish exposed to dexamethasone, pregnenolone-16alpha-carbonitrile, rifampicin, and beta-naphthoflavone.
Smith EM; Wilson JY
Aquat Toxicol; 2010 May; 97(4):324-33. PubMed ID: 20167382
[TBL] [Abstract][Full Text] [Related]
12. Inhibition and induction of cytochrome P450 and the clinical implications.
Lin JH; Lu AY
Clin Pharmacokinet; 1998 Nov; 35(5):361-90. PubMed ID: 9839089
[TBL] [Abstract][Full Text] [Related]
13. Cytochrome P450 expression and regulation in the brain.
Kuban W; Daniel WA
Drug Metab Rev; 2021 Feb; 53(1):1-29. PubMed ID: 33356626
[TBL] [Abstract][Full Text] [Related]
14. Alternative splicing within the human cytochrome P450 superfamily with an emphasis on the brain: The convolution continues.
Turman CM; Hatley JM; Ryder DJ; Ravindranath V; Strobel HW
Expert Opin Drug Metab Toxicol; 2006 Jun; 2(3):399-418. PubMed ID: 16863442
[TBL] [Abstract][Full Text] [Related]
15. Effect of prenatal exposure of deltamethrin on the ontogeny of xenobiotic metabolizing cytochrome P450s in the brain and liver of offsprings.
Johri A; Dhawan A; Lakhan Singh R; Parmar D
Toxicol Appl Pharmacol; 2006 Aug; 214(3):279-89. PubMed ID: 16494911
[TBL] [Abstract][Full Text] [Related]
16. Role of brain cytochrome P450 mono-oxygenases in bilirubin oxidation-specific induction and activity.
Gambaro SE; Robert MC; Tiribelli C; Gazzin S
Arch Toxicol; 2016 Feb; 90(2):279-90. PubMed ID: 25370011
[TBL] [Abstract][Full Text] [Related]
17. The potential impact of CYP and UGT drug-metabolizing enzymes on brain target site drug exposure.
Zhang M; Rottschäfer V; C M de Lange E
Drug Metab Rev; 2024 Feb; 56(1):1-30. PubMed ID: 38126313
[TBL] [Abstract][Full Text] [Related]
18. Cytochrome P450 (CYP) enzymes and the development of CYP biosensors.
Schneider E; Clark DS
Biosens Bioelectron; 2013 Jan; 39(1):1-13. PubMed ID: 22809523
[TBL] [Abstract][Full Text] [Related]
19. Antitumour prodrug development using cytochrome P450 (CYP) mediated activation.
Patterson LH; McKeown SR; Robson T; Gallagher R; Raleigh SM; Orr S
Anticancer Drug Des; 1999 Dec; 14(6):473-86. PubMed ID: 10834269
[TBL] [Abstract][Full Text] [Related]
20. Drug-metabolizing cytochrome P450s in the brain.
Miksys SL; Tyndale RF
J Psychiatry Neurosci; 2002 Nov; 27(6):406-15. PubMed ID: 12491573
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
